Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

DOCETAXEL

DOCETAXEL

Standard Dose
20MG/0.5ML (40MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview DOCETAXEL is listed in Drugs@FDA under application 201195 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient DOCETAXEL Form and strength INJECTABLE;INJECTION - 20MG/0.5ML (40MG/ML) Sponsor ACCORD HLTHCARE Submission history Latest submission status date: 2023-09-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview DOCETAXEL is listed in Drugs@FDA under application 201195 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DOCETAXEL Form and strength INJECTABLE;INJECTION - 20MG/0.5ML (40MG/ML) Sponsor ACCORD HLTHCARE Submission history Latest submission status date: 2023-09-20 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.